BeStock  

Aquestive Therapeutics AQST

US equityMarket cap rank #3651Drug Manufacturers - Specialty & Generic
$3.46 −$0.25 (-6.61%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.52 +1.73%
Open$3.62
Prev close$3.71
Day range$3.41 – $3.65
Volume3.36M
Market cap$434.88M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership57.5%-0.56 pts vs. prior quarter
Institutions holding208-1 vs. prior quarter
Insider trades (recent)22 buys / 26 sellsNet selling
Short interest23.36% of floatDays to cover 13.2 · as of 30 Oct 2026
Short-sale volume share21.0%5-day average of daily volume

Short-sale volume as % of daily volume

11%17%23%29%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$4.04M (5 inflow days, 15 outflow days).

Net flow by order size, last 20 sessions

−$2.3MSuper−$1.8MBig−$3.2MMid−$728.2KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 30.3% of shares outstanding.

Largest holders

  • BlackRock6.53%
  • Bratton Capital Management, L.P.7.82%
  • Thru Line L.P.6.27%
  • RTW Investments, LP5.91%
  • Vanguard Capital Management, LLC3.81%
  • State Street Global Advisors2.77%
  • Federated Hermes, Inc.2.54%
  • Geode Capital Management, LLC2.30%

By investor type

  • Mutual Fund34.08%
  • Hedge Fund12.75%
  • Public Company4.30%
  • Individual/Insider4.04%
  • VC/PE Fund2.74%
  • Private Company2.28%
  • Insurance Company0.79%
  • Family Office/Trust0.34%

Reported short interest has risen from 16.69% to 23.36% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Thru Line L.P. Mutual Fund 2026/Q3 +7,876,267 6.3%
Edward Bass Individual/Insider 2026/Q3 +1,509,294 1.2%
State Street Global Advisors Mutual Fund 2026/Q3 +553,371 2.8%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +272,745 2.3%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +199,669 3.8%
ProFund Advisors LLC Mutual Fund 2026/Q3 +163,019 0.2%
UBS Asset Management Mutual Fund 2026/Q3 +145,422 0.5%
BlackRock Mutual Fund 2026/Q3 +143,987 6.5%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +142,224 0.4%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +978,895 0.8%
Teachers Insurance and Annuity Association-College Retirement Equities Fund Mutual Fund 2026/Q3 +959,339 0.9%
Propel Bio Management, LLC Mutual Fund 2026/Q3 +731,409 1.1%
BlackRock Mutual Fund 2026/Q3 +560,302 6.4%
Wasatch Advisors LP Mutual Fund 2026/Q3 +507,527 1.1%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +416,248 0.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Nov 2026 Richard John Daly Independent Director Open Market Acquisition +28,025 $3.55 28,025
9 Nov 2026 Matthew Davis Chief Development Officer Sale to Issuer -5,303 $3.52 94,697
5 Nov 2026 Richard John Daly Independent Director Other Derivative Acquisition +57,000 $3.61 57,000
20 Oct 2026 John Cochran Independent Vice Chairperson Other Acquisition +62,229 – 161,715
14 Oct 2026 Richard John Daly Independent Director Initial Statement of Beneficial +0 – –
14 Oct 2026 Daniel Barber Chief Executive Officer Open Market Disposition -25,000 $4.22 627,317
14 Sep 2026 Daniel Barber Chief Executive Officer Open Market Disposition -25,000 $4.82 652,317
8 Sep 2026 Peter Boyd Senior Vice President of Information Technology & Chief People Officer Derivative Exercise and Retained +2,293 $0.96 284,024
8 Sep 2026 Sherry Korczynski Chief Commercial Officer Derivative Exercise and Sale -8,750 $5.22 235,689
7 Sep 2026 Daniel Barber Chief Executive Officer Derivative Exercise and Retained +91,743 $0.96 677,317
2 Sep 2026 Cassie Jung Chief Operating Officer Derivative Exercise and Retained +4,587 $0.96 208,833
16 Aug 2026 Daniel Barber Chief Executive Officer Open Market Disposition -25,000 $4.29 585,574
13 Aug 2026 Sherry Korczynski Chief Commercial Officer Sale to Issuer -2,714 $4.25 235,689
15 Jul 2026 Daniel Barber Chief Executive Officer Open Market Disposition -25,000 $4.03 610,574
14 Jul 2026 Daniel Barber Chief Executive Officer Intent to Sell (Form 144) -25,000 $4.04 –
22 Jun 2026 Julie Krop Independent Director Derivative Exercise and Sale -25,000 $5.02 –
14 Jun 2026 Daniel Barber Chief Executive Officer Open Market Disposition -25,000 $4.16 635,574
9 Jun 2026 Timothy Morris Independent Director Other Derivative Acquisition +50,500 $3.99 50,500
9 Jun 2026 Gregory Brown Independent Chairperson Other Derivative Acquisition +50,500 $3.99 50,500
9 Jun 2026 Julie Krop Independent Director Other Derivative Acquisition +50,500 $3.99 50,500

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 29,318,686 23.4% 13.2
15 Oct 2026 27,597,742 22.0% 13.9
30 Sep 2026 28,748,212 22.9% 13.1
15 Sep 2026 27,161,738 21.6% 11.8
31 Aug 2026 25,478,782 20.3% 7.2
14 Aug 2026 20,951,747 16.7% 5.2

Discussion

No comments yet — be the first to weigh in on AQST.

Sign in to join the discussion.

Scroll to Top